Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P631 Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases. -A nationwide, retrospective study

Autor: M Kutschera, V Ritschl, R Berthold, T Stamm, H Kiener, H Maier, W Reinisch, B Benka, G Novacek

Publikováno v: Journal of Crohn's and Colitis. 16:i552-i554

Background Immunosuppressive and biological medications are a mainstay in the treatment of immune-mediated diseases, such as inflammatory bowel diseases (IBD), rheumatic diseases, and psoriasis. However, the COVID-19 pandemic caused concerns over the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d159ec664b02af6bca2db97b5f414dec
https://doi.org/10.1093/ecco-jcc/jjab232.757

Zobrazit plný text záznamu

Das Therapieansprechen auf systemische Kortikosteroide bei Patienten mit aktiver Colitis ulcerosa ist mit der Regeneration des Mikrobioms und erhöhter mikrobielle Butyratproduktion assoziiert

Publikováno v: Zeitschrift für Gastroenterologie.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5394c0e0598dc8c08b37e79acaf6909e
https://doi.org/10.1055/s-0042-1755726

Zobrazit plný text záznamu

P785 A retrospective cohort study on vedolizumab trough levels in Crohn’s disease patients

Autor: J Pokryszka, M Stadlmann, C Primas, N Gerold, S Reinisch, G Novacek, W Reinisch

Publikováno v: Journal of Crohn's and Colitis. 17:i919-i919

Background Background: Vedolizumab (VDZ), an α47-integrin inhibitor, is approved for the treatment of moderate to severe Crohn’s disease (CD). Exposure-response relationship for VDZ is less evident in CD. Here, we are exploring associations betwee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a901e28f9693d60c27906ded5331941a
https://doi.org/10.1093/ecco-jcc/jjac190.0915

Zobrazit plný text záznamu

Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination

BackgroundKnowledge about humoral and cellular immunogenicity and their kinetics following SARS-CoV-2 mRNA vaccinations in immunosuppressed patients is limited.MethodsAntibody and cytokine responses were assessed in 263 patients with either solid tum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d4a9f0ba3bdc09f45aa8cff3ffb805a
https://doi.org/10.1101/2021.12.13.21267603

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P264 Prevalence and predictors of stoma formation and restoration of intestinal continuity in patients with Crohn’s disease in a tertiary referral hospital: A retrospective explorative study

Autor: C Primas, T Waldhör, K Kozbial, C Dawoud, S Riss, W Reinisch, M Niapri, M Kutschera, L Kazemi-Shirazi, S Reinisch, S Dabsch, N Pedarnig, H Angermann, G Novacek

Publikováno v: Journal of Crohn's and Colitis. 16:i304-i305

Background Crohn’s disease (CD) is associated with a high risk of intestinal complications such as stricture, fistula and abscess formation, as well as perianal disease, frequently requiring surgical procedures and intestinal stoma formation. The a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c445af89c2815dfa6a5326f88796731a
https://doi.org/10.1093/ecco-jcc/jjab232.391

Zobrazit plný text záznamu

POS1243 ACCELERATED WANING OF PROTECTIVE IMMUNITY AFTER SARS-CoV-2 mRNA VACCINATION IN PATIENTS TREATED WITH BIOLOGICAL AND TARGETED SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS

Autor: S. Tobudic, E. Simader, T. Deimel, P. Mandl, H. Haslacher, T. Perkmann, L. Schneider, T. Nothnagl, H. Lechner-Radner, F. Winkler, H. Burgmann, K. Stiasny, G. Novacek, W. Reinisch, D. Aletaha, S. Winkler, S. Blüml

Publikováno v: Annals of the Rheumatic Diseases. 81:955.2-956

BackgroundLittle is known about the duration of humoral antibody levels after two SARS-CoV-2 mRNA vaccinations in patients with immunosuppression. During this ongoing global epidemic, it is of essential interest to gather information about the time o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d08e0feb3810f4a27b8bfd83195b630b
https://doi.org/10.1136/annrheumdis-2022-eular.3232

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání